Zevra Therapeutics, Inc (ZVRA) insider trading
Every open-market stock purchase and sale by Zevra Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Rahsaan Thompson (Officer) and 1 other sold $613K in the last 90 days.
- Last insider buy: Alvin Shih (Director), $158K, 13 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.5M (13 sales). Last close $12.13 on Aug 19, 2026.
Recent ZVRA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 14, 2026 | Rahsaan Thompson (Officer) | Sold | $475K |
| Aug 10, 2026 | Corey Michael Watton (Director) | Sold | $138K |
| Aug 10, 2026 | Corey Michael Watton (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Rahsaan Thompson (Officer) | Sold | $438K |
| Jun 21, 2026 | Rahsaan Thompson (Officer) | Bought (not open market) | — |
| Jun 4, 2026 | Alvin Shih (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Alicia Secor (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Tamara A Favorito (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Douglas W Calder (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Thomas Anderson (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Corey Michael Watton (Director) | Bought (not open market) | — |
| May 28, 2026 | Timothy J. Sangiovanni (VP) | Bought (not open market) | — |
| May 28, 2026 | Timothy J. Sangiovanni (VP) | Bought (not open market) | — |
| May 11, 2026 | Rahsaan Thompson (Officer) | Sold | $20.3K |
| Mar 24, 2026 | John B Bode (Director) | Bought (not open market) | — |
| Mar 18, 2026 | Justin A Renz (CFO) | Bought (not open market) | — |
| Feb 9, 2026 | Neil F. McFarlane (CEO) | Sold | $125K |
| Feb 7, 2026 | Neil F. McFarlane (CEO) | Bought (not open market) | — |
| Feb 3, 2026 | Joshua Schafer (C-suite exec) | Sold | $96.5K |
| Feb 3, 2026 | Timothy J. Sangiovanni (VP) | Sold | $27.5K |
| Feb 2, 2026 | Neil F. McFarlane (CEO) | Sold | $853K |
| Jan 31, 2026 | Joshua Schafer (C-suite exec) | Bought (not open market) | — |
| Jan 31, 2026 | Timothy J. Sangiovanni (VP) | Bought (not open market) | — |
| Jan 31, 2026 | Neil F. McFarlane (CEO) | Bought (not open market) | — |
| Jan 30, 2026 | Adrian W Quartel (C-suite exec) | Sold | $40K |
Who's trading ZVRA
- Rahsaan Thompson, Officer: sold $969K (4 sales), last Aug 14, 2026
- Corey Michael Watton, Director: sold $138K (1 sale), last Aug 10, 2026
- Thomas Anderson, Director: other filings, last Jun 4, 2026
- Douglas W Calder, Director: other filings, last Jun 4, 2026
- Tamara A Favorito, Director: other filings, last Jun 4, 2026
- Alicia Secor, Director: other filings, last Jun 4, 2026
- Alvin Shih, Director: other filings, last Jun 4, 2026
- Timothy J. Sangiovanni, VP: sold $43K (2 sales), last May 28, 2026
- John B Bode, Director: other filings, last Mar 24, 2026
- Justin A Renz, CFO: other filings, last Mar 18, 2026
- Neil F. McFarlane, CEO: sold $1.2M (3 sales), last Feb 9, 2026
- Joshua Schafer, C-suite exec: sold $126K (2 sales), last Feb 3, 2026
- Adrian W Quartel, C-suite exec: sold $40K (1 sale), last Jan 30, 2026
- R. LaDuane Clifton, CFO: other filings, last Dec 31, 2025
Get free alerts when an insider at Zevra Therapeutics, Inc files a new trade →